Institutional members access full text with Ovid®

Share this article on:

Differentiation of Benign and Malignant Neck Pathologies: Preliminary Experience Using Spectral Computed Tomography

Srinivasan, Ashok MD; Parker, Robert A. ScD; Manjunathan, Abhishek; Ibrahim, Mohannad MD; Shah, Gaurang V. MD; Mukherji, Suresh K. MD

Journal of Computer Assisted Tomography: September/October 2013 - Volume 37 - Issue 5 - p 666–672
doi: 10.1097/RCT.0b013e3182976365

Purpose The objective of this study was to evaluate spectral Hounsfield unit (HU) curves and effective Z (atomic number) generated on dual-energy gemstone spectral imaging computed tomography (CT) in the differentiation of benign and malignant neck pathologic findings.

Methods This was a retrospective review of 38 patients who underwent neck CT on a gemstone spectral imaging dual-energy CT (Lightspeed CT750 HD 64-slice CT scanner; GE Medical Systems, Milwaukee, Wis) from November 2009 to June 2012 with identifiable masses. One board-certified radiologist placed regions of interest within the mass (19 benign, 19 malignant) and in paraspinal muscles (PSMs) to create 2 spectral HU curves in each patient. The curve parameters compared between the benign and malignant groups included range (conceptually, the difference between the highest and lowest HU), asymptote, decay, and the differences and ratios (of lesion to PSM) of each of these 3 parameters. A logistic regression model was built with these parameters and effective Z.

Results The difference in ranges (between lesion and PSM) was the best predictor of malignancy, with a threshold of 75 or greater demonstrating 95% sensitivity, 89% specificity, and 91.8% area under the curve (AUC). Adding other spectral HU parameters and effective Z to the model did not substantially increase the AUC (93.3%, difference between the 2 models not statistically significant, P > 0.25). The effective Z showed a 79.9% AUC with 68% sensitivity and 68% specificity at an 8.80 cutoff.

Conclusions The spectral HU curve is promising for differentiating benign and malignant neck pathologic findings, with the difference in range between the lesion and PSM showing the best predictive value.

*From the Division of Neuroradiology, Department of Radiology, University of Michigan Health System; †Department of Biostatistics, School of Public Health, Michigan Institute for Clinical & Health Research; and ‡University of Michigan Ross School of Business, Ann Arbor, MI.

Received for publication January 28, 2013; accepted March 15, 2013.

Reprints: Ashok Srinivasan, MD, Division of Neuroradiology, Department of Radiology, University of Michigan Health System, 1500 E Medical Center Dr, Ann Arbor, MI 48109 (e-mail:

The authors declare that they do not have any conflict of interest pertaining to this study.

Copyright © 2013 Wolters Kluwer Health, Inc. All rights reserved.